Akebia Therapeutics | AKBA - Выручка от реализации





Продажи Изменить Дата
Acadia Pharmaceuticals USD 284M 5.4M 2025-12
Agios Pharmaceuticals USD 19.97M 7.07M 2025-12
Akebia Therapeutics USD 57.62M 1.14M 2025-12
Alnylam Pharmaceuticals USD 1.1B 150M 2025-12
Amgen USD 9.9B 340M 2025-12
Ardelyx USD 125.21M 14.89M 2025-12
Astellas Pharma JPY 571.21B 46.89B 2025-12
AstraZeneca USD 15.5B 313M 2025-12
Bayer EUR 11.44B 1.78B 2025-12
BioMarin Pharmaceutical USD 875M 99M 2025-12
Celltrion KRW 1.33T 0 2026-03
Cspc Pharmaceutical CNY 6.62B 358.95M 2025-09
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 284K 112K 2025-12
Exelixis USD 598.66M 860K 2025-12
Fresenius Medical Care EUR 5.07B 180M 2025-12
GlaxoSmithKline GBP 8.62B 73M 2025-12
Ionis Pharmaceuticals USD 203M 46M 2025-12
Ironwood Pharmaceuticals USD 47.71M 74.35M 2025-12
J&J USD 24.6B 610M 2025-12
Kangmei Pharma CNY 1.37B 101.16M 2025-09
Karyopharm Therapeutics USD 30.54M 8.24M 2024-12
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Lexicon Pharmaceuticals USD 5.49M 8.69M 2025-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Moderna USD 678M 342M 2025-12
Nektar Therapeutics USD 24.12M 635K 2024-09
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Organigram Holdings CAD 63.54M 16.52M 2025-12
Pharma Mar EUR 90.2M 54.5M 2025-12
Prothena USD 21K 2.4M 2025-12
PTC Therapeutics USD 164.7M 46.3M 2025-12
Qiagen NV USD 457.38M 6.06M 2025-12
Regeneron Pharmaceuticals USD 3.88B 130M 2025-12
Roche Holding CHF 15.65B 274.5M 2025-12
Sanofi EUR 11.3B 1.13B 2025-12
Sarepta Therapeutics USD 442.9M 43.5M 2025-12
Sartorius EUR 927.6M 84.4M 2025-12
Sino Biopharmaceutical CNY 17.57B 4.58B 2025-06
Tectonic Therapeutic USD 0 0 2024-12
Tilray USD 217.51M 74.75M 2025-12
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Zealand Pharma A/S 68.91M 19.35M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M 2025-09